CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Novartis AG

NOVN.SW
$221.62B
Mega Cap
SIXBiotechnology🇺🇸North America75.9K employees

Drugs in Pipeline

396

Phase 3 Programs

244

Upcoming Catalysts

10

Next Catalyst

Feb 28, 2026

20d
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply

Market Overview

Stock performance and market intelligence

Catalyst Timeline

10 upcoming, 1 past

⭐Phase 3Next

JDQ443 Phase 3 Results Expected

Feb 28, 2026JDQ44395

Primary completion for JDQ443 trial (NCT05132075) in Non-Small Cell Lung Cancer

Source
⭐Phase 3

Remibrutinib Phase 3 Results Expected

Mar 30, 2026Remibrutinib364

Primary completion for Remibrutinib trial (NCT05976243) in Chronic Inducible Urticaria

Source
⭐Phase 3

placebo Phase 3 Results Expected

Apr 2, 2026Vildagliptin 50 mg bid100

Primary completion for placebo trial (NCT05677451) in Chronic Spontaneous Urticaria

Source
⭐Phase 3

LOU064 (blinded) Phase 3 Results Expected

Apr 2, 2026LOU064 (blinded)100

Primary completion for LOU064 (blinded) trial (NCT05677451) in Chronic Spontaneous Urticaria

Source
Phase 2

CPK850 Phase 2 Results Expected

May 11, 2026CPK85012

Primary completion for CPK850 trial (NCT03374657) in Retinitis Pigmentosa

Source
Phase 2

INE963 Phase 2 Results Expected

Jun 9, 2026INE963327

Primary completion for INE963 trial (NCT05750628) in Uncomplicated Plasmodium Falciparum Malaria

Source
Phase 2

68Ga-FAP-2286 Phase 2 Results Expected

Jun 30, 202668Ga-FAP-2286222

Primary completion for 68Ga-FAP-2286 trial (NCT04939610) in Solid Tumor

Source
Phase 2

VHB937 Phase 2 Results Expected

Sep 21, 2026VHB937251

Primary completion for VHB937 trial (NCT06643481) in Amyotrophic Lateral Sclerosis (ALS)

Source
Phase 2

Iptacopan (LNP023) Phase 2 Results Expected

Oct 1, 2026Iptacopan (LNP023)170

Primary completion for Iptacopan (LNP023) trial (NCT05230537) in Age-Related Macular Degeneration

Source
⭐Phase 3

Ofatumumab approved dose Phase 3 Results Expected

Dec 24, 2026Ofatumumab approved dose180

Primary completion for Ofatumumab approved dose trial (NCT06869785) in Relapsing Multiple Sclerosis (RMS)

Source

AI Predictions & Institutional Flow

Machine learning insights and smart money movement

FDA Submissions

Pending NDA/BLA submissions with predicted PDUFA dates

Drug Pipeline

Clinical development programs and drug candidates

Drug Pipeline

VALSARTAN, VALSARTAN+HYDROCHLOROTHIAZIDE

Phase 3

Hypertension

GP2017 (adalimumab biosimilar)

Phase 3

Ankylosing Spondylitis

Olaparib

Phase 3

Ovarian Cancer

Enteric-coated Mycophenolate Sodium

Phase 3

Autoimmune Disease

Valsartan 160 mg capsules

Phase 3

Essential Hypertension

Pelabresib

Phase 3

Myelofibrosis

Labeled regime arm

Phase 3

Diabetic Macular Edema

LCZ

Phase 3

Hypertension

Abatacept

Phase 3

Rheumatoid Arthritis

lamivudine

Phase 3

Chronic Hepatitis B

Brolucizumab 6 mg

Phase 3

Neovascular Age-related Macular Degeneration

Mycophenolate sodium

Phase 3

Kidney Transplantation

Secukinumab 300 mg

Phase 3

Chronic Scalp Psoriasis

[18F]CTT1057

Phase 3

Prostatic Neoplasms

Ribociclib

Phase 3

Advanced, Metastatic Breast Cancer

brolucizumab

Phase 3

Neovascular Age-related Macular Degeneration

lumiracoxib

Phase 3

Osteoarthritis

Ruxolitinib

Phase 3

Cytokine Storm (Covid-19)

Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine

Phase 3

Swine-Origin Influenza A H1N1 Virus

agomelatine

Phase 3

Major Depressive Disorder (MDD)

Diclofenac sodium gel 1%

Phase 3

Muscle Soreness

metformin

Phase 3

Diabetes Mellitus, Type 2

pioglitazone

Phase 3

Diabetes Mellitus, Type 2

rMenB + OMV NZ vaccine

Phase 3

Meningococcal Disease

Long-acting beta 2-agonist (LABA)

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

Valsartan + Amlodipine besilate

Phase 3

Hypertension

Remibrutinib

Phase 3

Chronic Inducible Urticaria

Pazopanib

Phase 3

Advanced Renal Cell Carcinoma

AMN107

Phase 3

Leukemia, Myeloid, Chronic

Vaxem Hib (Haemophilus influenzae type b (Hib) vaccine)

Phase 3

Haemophilus Influenzae Type b (Hib) Infection

Tetanus toxoid vaccine

Phase 3

Relapsing Multiple Sclerosis

Ritalin LA (methylphenidate hydrochloride extended release)

Phase 3

Attention Deficit/Hyperactivity Disorder

Fevipiprant 150 mg

Phase 3

Nasal Polyps

LMF237 50/250 mg

Phase 3

Diabetes Mellitus, Type 2

indacaterol and glycopyrronium bromide (QVA149)

Phase 3

COPD

alpelisib

Phase 3

Breast Cancer

Cyclosporine A microemulsion

Phase 3

Chronic Plaque Psoriasis

Fulvestrant

Phase 3

Advanced Breast Cancer

TIVc_LOT A

Phase 3

Prophylaxis: Influenza

Budesonide

Phase 3

Asthma

Mycophenolic Acid (MPA)

Phase 3

Kidney Transplantation

Enalapril

Phase 3

Chronic Heart Failure

valsartan+amlodipine combination, valsartan, amlodipine

Phase 3

Hypertension

Secukinumab (150 mg)

Phase 3

Psoriatic Arthritis

1 dose of Meningococcal (group B) multicomponent recombinant adsorbed vaccine

Phase 3

Meningococcal Disease

Secukinumab 150 mg

Phase 3

Giant Cell Arteritis (GCA)

Haemophilus influenzae type b (Hib) vaccine

Phase 3

Haemophilus Influenzae Type b (Hib) Infection

Ansastrozole

Phase 3

Early Breast Cancer

First line DMT

Phase 3

Multiple Sclerosis

Iptcaopan 200 mg

Phase 3

Atypical Hemolytic Uremic Syndrome

Aliskiren/amlodipine 300/10 mg tablet

Phase 3

Moderate to Severe Hypertension

Verteporfin photodynamic therapy

Phase 3

Macular Degeneration

LOU064

Phase 3

Chronic Spontaneous Urticaria

Glycopyrronium bromide

Phase 3

Chronic Obstructive Pulmonary Disease

LOU064 25 mg (b.i.d)

Phase 3

Chronic Spontaneous Urticaria

valsartan + amlodipine

Phase 3

Hypertension

Meningococcal B Recombinant vaccine rMenB+OMV NZ

Phase 3

Meningococcal Disease

Fluvastatin

Phase 3

Heterozygous Familial Hypercholesterolemia

Remibrutinib Dose A

Phase 3

Hidradenitis Suppurativa

indacaterol and glycopyrronium (QVA149)

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

QMF149 150/80 μg

Phase 3

Mild Asthma

Everolimus and tacrolimus

Phase 3

Kidney Transplant

MenACWY-CRM + MMRV

Phase 3

Meningococcal Infections

lisinopril

Phase 3

Hypertension

Nilotinib

Phase 3

Chronic Myelogenous Leukemia

ACZ885

Phase 3

Sickle Cell Anemia

Dexmethylphenidate HCl extended-release capsules

Phase 3

ADHD, ADD

Rabies vaccines + Rabies immunoglobulins

Phase 3

Rabies Infection

LCZ696

Phase 3

Heart Failure With Preserved Ejection Fraction

Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011

Phase 3

Seasonal Influenza

Novartis MenACWY-CRM

Phase 3

Meningococcal Disease

Everolimus (Certican)

Phase 3

Organ Transplantation, Renal Transplantation

FTY720

Phase 3

Renal Transplantation

177Lu-PSMA-617

Phase 3

Prostatic Neoplasms

Secukinumab (75 mg)

Phase 3

Anklyosing Spondylitis

omalizumab

Phase 3

Asthma

Lot A of Influenza virus vaccine

Phase 3

Influenza

Aliskiren (6.25/12.5/25 mg)

Phase 3

Hypertension

Routine Vaccines

Phase 3

Meningococcal Disease

Midostaurin

Phase 3

Acute Myeloid Leukemia (AML)

QMF149

Phase 3

Asthma

QAB149

Phase 3

COPD

FTY 720

Phase 3

Kidney Transplantation

AAA817

Phase 3

Prostate Cancer

Monovalent A/H1N1 influenza vaccine

Phase 3

Pandemic Influenza Disease

MF59-eH1N1_f

Phase 3

Influenza

terbinafine

Phase 3

Onychomycosis

Ofatumumab

Phase 3

Chronic Lymphocytic Leukemia (CLL)

MenACWY-CRM

Phase 3

Meningococcal Disease

rMenB+OMV NZ

Phase 3

Prevention of the Meningococcal Disease

canakinumab (company code: ACZ885D)

Phase 3

Cryopyrin Associated Periodic Syndrome

Seasonal Influenza Vaccine

Phase 3

Seasonal Influenza

Siponimod

Phase 3

Multiple Sclerosis

Everolimus + Cyclosporine

Phase 3

Renal Transplantation

Risedronate

Phase 3

Paget's Disease of Bone

Iptacopan

Phase 3

Paroxysmal Nocturnal Hemoglobinuria

Pimecrolimus Cream 1%

Phase 3

Atopic Dermatitis

Daptomycin

Phase 3

Infections

Deferasirox

Phase 3

Myelodysplastic Syndromes

Darifenacin

Phase 3

Overactive Bladder Syndrome

Umeclidinium/vilanterol

Phase 3

Chronic Obstructive Pulmonary Disease

LCQ908

Phase 3

Non Familial Chylocmicronemia Syndrome (Non-FCS)

telbivudine or lamivudine

Phase 3

Chronic Hepatitis B

TIVc

Phase 3

Influenza

rMenB+OMV NZ with routine vaccinations

Phase 3

Meningococcal Disease

Typhoid Vi Polysaccharide Vaccine

Phase 3

Meningococcal Disease

vildagliptin + metformin

Phase 3

Diabetes Mellitus, Type 2

NVA237 50µg once daily

Phase 3

Chronic Obstructive Pulmonary Disease

Secukinumab 2 mL form

Phase 3

Psoriasis

VAY736

Phase 3

Sjogren Syndrome

Inclisiran

Phase 3

Atherosclerotic Cardiovascular Disease

sacubitril/valsartan

Phase 3

Heart Failure With Preserved Ejection Fraction (HFpEF)

ICL670

Phase 3

Beta-Thalassemia

Inclisiran Sodium for injection

Phase 3

Homozygous Familial Hypercholesterolemia

paroxetine

Phase 3

Major Depressive Disorder

salbutamol/albuterol

Phase 3

Chronic Obstructive Pulmonary Disease

Ianalumab (VAY736)

Phase 3

Sjogrens Syndrome

Myfortic

Phase 3

Kidney Transplantation

Rivastigmine Patch

Phase 3

Alzheimer's Disease

Imatinib Mesylate

Phase 3

Philadelphia Chromosome Positive Acute Lymphocytic Leukemia

Abbreviated Zagreb 2-1-1 schedule

Phase 3

Rabies

mycophenolate mofetil

Phase 3

Graft Rejection

Panobinostat

Phase 3

Hodgkin's Lymphoma

Novartis Meningococcal ACWY Conjugate Vaccine

Phase 3

Meningococcal Meningitis

Secukinumab/Adalimumab-Biosimilar

Phase 3

Axial Spondyloarthritis

Atenolol

Phase 3

Hypertension

Artemether-lumefantrine

Phase 3

Plasmodium Falciparum Malaria

Meningococcal (group B) multicomponent recombinant adsorbed vaccine

Phase 3

Meningitis, Meningococcal, Serogroup B

RLX030

Phase 3

Acute Heart Failure

Ceritinib

Phase 3

Non-Small Cell Lung Cancer

Lapatinib

Phase 3

Neoplasms, Gastrointestinal Tract

Exemestane

Phase 3

Breast Cancer

Clozapine

Phase 3

Schizophrenia

indacaterol maleate

Phase 3

Asthma

Olmesartan

Phase 3

Hypertension

Ranibizumab 0.5mg

Phase 3

Age-related Macular Degeneration

Valsartan/amlodipine 80/5 mg

Phase 3

Hypertension

telbivudine

Phase 3

Hepatitis B

Diclofenac Topical Sodium Gel 1%

Phase 3

Osteoarthritis

Ligelizumab

Phase 3

Chronic Spontaneous Urticaria

Pasireotide

Phase 3

Cushing Disease

inclisiran sodium

Phase 3

Hypercholesterolemia

hydrochlorothiazide

Phase 3

Hypertension

Aliskiren/hydrochlorothiazide (HCTZ) (300/25 mg)

Phase 3

Hypertension

ianalumab s.c. q4w

Phase 3

Lupus Nephritis

oxcarbazepine

Phase 3

Epilepsy

Crizanlizumab

Phase 3

Sickle Cell Disease

Best Available Therapy

Phase 3

Polycythemia Vera

valsartan plus hydrochlorothiazide

Phase 3

Hypertension

basiliximab, MMF(mycophenolate mofetil), cyclosporine, prednisone (or equivalent)

Phase 3

Pediatric Kidney Transplantation

Valsartan and simvastatin

Phase 3

Hypertension

Pelacarsen (TQJ230) 80 mg s.c.

Phase 3

Hyperlipoproteinemia(a)

AIN457 150mg

Phase 3

Moderate to Severe Plaque-type Psoriasis

ranibizumab 0.5 mg

Phase 3

Age Related Macular Degeneration

Basiliximab

Phase 3

Liver Transplant

Tiotropium

Phase 3

Chronic Obstructive Pulmonary Disease

Gliclazide

Phase 3

Diabetes Mellitus, Type 2

Pimecrolimus

Phase 3

Atopic Dermatitis

TQJ230

Phase 3

Cardiovascular Disease and Lipoprotein(a)

Onasemnogene Abeparvovec-xioi

Phase 3

SMA

QVM149 150/50/160

Phase 3

Asthma

RTH258

Phase 3

Neovascular Age Related Macular Degeneration

Imatinib

Phase 3

Leukemia

Ezetimibe

Phase 3

Hypercholesterolemia

Dupilumab

Phase 3

Chronic Spontaneous Urticaria (CSU)

Tamoxifen

Phase 3

Advanced Metastatic Breast Cancer

Telbivudine (LdT)

Phase 3

Chronic Hepatitis B

Ramipril

Phase 3

Hypertension

Everolimus

Phase 3

Hormone Receptor Positive Breast Cancer

valsartan

Phase 3

Hypertension

Vildagliptin 50 mg bid

Phase 3

Type 2 Diabetes Mellitus

QVM149

Phase 3

Asthma

vildagliptin

Phase 3

Diabetes Mellitus, Type 2

NVA237

Phase 3

Chronic Obstructive Pulmonary Disease

Ranibizumab

Phase 3

Pathological Myopia

LOU064 (blinded)

Phase 3

Chronic Spontaneous Urticaria

Octreotide LAR

Phase 3

Acromegaly

OFC Infusion

Phase 3

Leukaemia, Lymphocytic, Chronic

Aliskiren

Phase 3

Hypertension

Secukinumab

Phase 3

Polymyalgia Rheumatica

zoledronic acid

Phase 3

Prostate Cancer

Sitagliptin

Phase 3

Diabetes Mellitus, Type 2

Tegaserod

Phase 3

Gastroesophageal Reflux Disease (GERD)

osilodrostat

Phase 3

Cushings Disease

Indacaterol

Phase 3

Asthma

Tobramycin Inhalation Powder

Phase 3

Cystic Fibrosis

KLU156

Phase 3

Uncomplicated Plasmodium Falciparum Malaria

thiazolidinedione (TZD)

Phase 3

Diabetes Mellitus, Type 2

Vildagliptin 100 mg qd

Phase 3

Diabetes Mellitus, Type 2

tobramycin

Phase 3

Pseudomonas Infections

rabies vaccine

Phase 3

Rabies Post-exposure Prophylaxis

Cell derived subunit trivalent nonadjuvanted vaccine

Phase 3

Influenza

irbesartan

Phase 3

Hypertension

LNP023

Phase 3

IgA Nephropathy

RAD001

Phase 3

Metastatic Renal Cell Carcinoma

Dexamethasone implant and sham injections

Phase 3

Visual Impairment

Canakinumab

Phase 3

Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia

AIN457

Phase 3

Chronic Plaque Psoriasis

ABL001

Phase 3

Chronic Myelogenous Leukemia - Chronic Phase

Canakinumab (ACZ885)

Phase 3

Cryopyrin-Associated Periodic Syndromes

Ustekinumab

Phase 3

Psoriatic Arthritis

Ofatumumab approved dose

Phase 3

Relapsing Multiple Sclerosis (RMS)

Certican®

Phase 3

Renal Interstitial Fibrosis

Hydrochlorothiazide (HCTZ)

Phase 3

Hypertension

Octreotide Long Acting Release

Phase 3

Chemotherapy-induced Diarrhea

Secukinumab 150 mg s.c.

Phase 3

Plaque Psoriasis

Tobramycin solution for inhalation 300 mg

Phase 3

Cystic Fibrosis

AIN457 150 mg

Phase 3

Moderate to Severe Chronic Plaque-Type Psoriasis

valsartan/amlodipine

Phase 3

Hypertension

JDQ443

Phase 3

Non-Small Cell Lung Cancer

Enteric-coated Mycophenolate sodium (EC-MPS), valsartan

Phase 3

De Novo Renal Transplantation

Active Comparator

Phase 3

Alzheimer's Disease

RTH258/Brolucizumab

Phase 3

Neovascular Age-Related Macular Degeneration

Remibrutinib oral treatment

Phase 3

Relapsing Multiple Sclerosis

Glimepiride

Phase 3

Type II Diabetes Mellitus

QAW039

Phase 3

Allergic Rhinitis

Licarbazepine

Phase 3

Bipolar I Disorder

Recombinant meningococcal B + OMV NZ

Phase 3

Meningococcal Disease

Octreotide

Phase 3

Acromegaly

Cytarabine

Phase 3

Acute Myeloid Leukemia

amlodipine

Phase 3

Hypertension

Salmeterol 50 μg

Phase 3

Chronic Obstructive Pulmonary Disease

Everolimus (RAD001)

Phase 3

Renal Transplantation

Lansoprazole

Phase 3

Frequent Heartburn

Octreotide acetate 30 mg suspension

Phase 3

Acromegaly

Losartan

Phase 3

Hypertension; Hypertrophy, Left Ventricular

EC-MPS

Phase 3

Patients Successfully Completing the 12-month Treatment Period of the Core Study (de Novo Heart Recipients) Who Were Interested of Being Treated With EC-MPS

Enteric-coated Mycophenolate sodium (EC-MPS)

Phase 3

Kidney Transplant Recipients

Ianalumab

Phase 3

Diffuse Cutaneous Systemic Sclerosis

Calcium and vitamin D supplements

Phase 3

Paget's Disease of Bone

Brolucizumab 6mg

Phase 3

Neovascular Age-Related Macular Degeneration

Xylometazoline

Phase 3

Common Cold

Aliskiren 300 mg

Phase 3

Hypertension

pasireotide LAR

Phase 3

Cushing's Disease

Secukinumab (AIN457)

Phase 3

Moderate to Severe Plaque-type Psoriasis

Letrozole

Phase 3

Breast Cancer

Famciclovir

Phase 3

Recurrent Genital Herpes

QVA149

Phase 3

Chronic Obstructive Pulmonary Disease

Fingolimod

Phase 3

Multiple Sclerosis

Meningococcal ACWY Polysaccharide Vaccine

Phase 3

Meningococcal Meningitis

Bosutinib

Phase 3

Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive

Rivastigmine 5 cm^2

Phase 3

Alzheimer Disease

Ruxolitinib (RUX)

Phase 3

Corticosteroid Refractory Acute Graft vs Host Disease

Canakinumab 150 mg

Phase 3

Acute Gout

INE963

Phase 2

Uncomplicated Plasmodium Falciparum Malaria

Treosulfane

Phase 2

Prostate Cancer

GSK2118436

Phase 2

Cancer

asciminib

Phase 2

Chronic Myelogenous Leukemia - Chronic Phase

H5N1 influenza vaccine

Phase 2

Avian Influenza

Cipargamin

Phase 2

Uncomplicated Plasmodium Falciparum Malaria

AEB071

Phase 2

Kidney Transplantation

AAA617

Phase 2

Metastatic Castration Resistant Prostate Cancer (mCRPC)

Lapatinib/nab-Paclitaxel

Phase 2

Neoplasms, Breast

CTL019

Phase 2

B-Cell Acute Lymphoblastic Leukemia

bimagrumab

Phase 2

Sarcopenia

Dexamethasone

Phase 2

Immune Thrombocytopenia (ITP)

BHQ880

Phase 2

Multiple Myeloma

Surface Antigen, Inactivated, Adjuvanted, Influenza Vaccine, Formulation 2007-2008

Phase 2

Influenza

[177Lu]Lu-PSMA-617

Phase 2

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

SPP100

Phase 2

Hypertension

PTK787

Phase 2

Wet Age-Related Macular Degeneration

BZF961

Phase 2

Hepatitis C

CNP520

Phase 2

Alzheimer's Disease

Panobinostat/LBH589

Phase 2

Refractory Leukemia

CPK850

Phase 2

Retinitis Pigmentosa

MenACWY polysaccharide vaccine

Phase 2

Meningococcal Meningitis

Evolocumab

Phase 2

Atherosclerotic Cardiovascular Disease

AHU377

Phase 2

Systolic Hypertension

BAF312 solution

Phase 2

Hemorrhagic Stroke

Deferasirox (ICL670)

Phase 2

Iron Overload

Capmatinib

Phase 2

Carcinoma, Non-Small-Cell Lung

ACZ885 (investigational)

Phase 2

Rheumatoid Arthritis

Certoparin 3,000 IU Once Daily

Phase 2

Renal Insufficiency

ABL001/Asciminib

Phase 2

Chronic Myeloid Leukemia (CML)

CFZ533 active - Cohort 1

Phase 2

Primary Sjögren's Syndrome

ARV-766 Part A&B

Phase 2

Prostate Cancer Metastatic

rMenB+OMV

Phase 2

Healthy

LHW090

Phase 2

Chronic Kidney Disease (CKD)

CJM112

Phase 2

Acne Vulgaris

NIM811

Phase 2

Chronic Hepatitis C Genotype-1 Relapse

STI571

Phase 2

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

CAD106

Phase 2

Alzheimer Disease

AFQ056

Phase 2

Fragile X Syndrome

RAD001(everolimus)

Phase 2

Carcinoma

BYL719

Phase 2

Breast Cancer

68Ga-FAP-2286

Phase 2

Solid Tumor

LCI699

Phase 2

Primary Hyperaldosteronism

Adjuvanted H5N1 pandemic influenza vaccine

Phase 2

Pandemic H5N1 Influenza

Mometasone furoate/formoterol fumarate (MFF)

Phase 2

Asthma

AIN457A

Phase 2

Chronic Plaque-type Psoriasis

Iloperidone crystalline formulation

Phase 2

Schizophrenia

CSJ117

Phase 2

Pulmonary Disease, Chronic Obstructive

TCH346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt)

Phase 2

Parkinson's Disease

Seasonal Influenza Vaccine (MF59C.1)

Phase 2

Seasonal Influenza

STI571 (Glivec®)

Phase 2

Prostatic Neoplasm

MenC-CRM LIQ

Phase 2

Meningococcal Disease

LEE011

Phase 2

Teratoma

Lymphodepleting chemotherapy

Phase 2

Diffuse Large B-cell Lymphoma (DLBCL)

TIN816 70 mg lyophilisate powder

Phase 2

Acute Kidney Injury Due to Sepsis

FGF401

Phase 2

Hepatocellular Carcinoma (HCC)

Rapcabtagene autoleucel single agent

Phase 2

Chronic Lymphocytic Leukemia

Simulect®

Phase 2

Renal Transplantation

RFB002

Phase 2

Diabetic Macular Edema

CLR325

Phase 2

Chronic Stable Heart Failure

Seasonal flu vaccine

Phase 2

Seasonal Influenza

SBR759

Phase 2

Chronic Kidney Disease

Monovalent inactivated influenza vaccine

Phase 2

Prepandemic Influenza Vaccine

epothilone b

Phase 2

Prostatic Neoplasms

NVGH Vi-CRM197

Phase 2

Typhoid Fever

MenACWY-CRM conjugate vaccine, adjuvanted

Phase 2

Prevention of Meningococcal Disease

Indacaterol 150 μg via the Concept1 dry-powder inhaler

Phase 2

Asthma

MIJ821 Subcutaneous Injection 1 mg

Phase 2

Treatment-Resistant Depression

Surface Antigen, Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008

Phase 2

Influenza

Deferasirox and Deferoxamine

Phase 2

Cardiac Iron Overload

Dovitinib (TKI258)

Phase 2

Tumor Pathway Activations Inhibited by Dovitinib

VAK694

Phase 2

Allergic Rhinitis

sacubitril/valsartan (LCZ696)

Phase 2

Hypertension

Tulmimetostat

Phase 2

Advanced Solid Tumor

NVA237 12.5 µg once daily

Phase 2

Chronic Obstructive Pulmonary Disease

Goserelin

Phase 2

Breast Cancer

Glucocorticoids

Phase 2

ANCA Associated Vasculitis (AAV)

Colchicine

Phase 2

Gout

Glycopyrronium bromide 25ug

Phase 2

Asthma

BFH772 1% ointment

Phase 2

Erythemato-telangiectatic Rosacea

APL180

Phase 2

Coronary Heart Disease

XXB750 drug

Phase 2

Resistant Hypertension

Rapcabtagene autoleucel

Phase 2

Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD)

QBW251

Phase 2

Chronic Obstructive Pulmonary Disease, COPD

CMK389

Phase 2

Pulmonary Sarcoidosis

XBD173

Phase 2

Anxiety Disorders

LAG525

Phase 2

Advanced Solid Tumors

AUY922

Phase 2

Advanced Gastric Cancer

MAS825

Phase 2

Still´s Disease

LIK066

Phase 2

Obesity

Tisagenlecleucel

Phase 2

Non-Hodgkin Lymphoma

SMC021

Phase 2

Health Postmenopausal Women

H5N1 pandemic Influenza vaccine 3.75µg

Phase 2

Pandemic H5N1 Influenza

NVA237 100 µg

Phase 2

Chronic Obstructive Pulmonary Disease (COPD)

Trametinib

Phase 2

Melanoma and Brain Metastases

AAE581

Phase 2

Osteoporosis

SOM230

Phase 2

Dumping Syndrome

alb-interferon alfa 2b

Phase 2

Chronic Hepatitis C

JSB462

Phase 2

Metastatic Hormone-sensitive Prostate Cancer

KAE609

Phase 2

Malaria

PDR001

Phase 2

Melanoma

Atrasentan

Phase 2

IgA Nephropathy

Coartem

Phase 2

Acute Uncomplicated Plasmodium Falciparum Malaria

HCD122

Phase 2

Non-Hodgkin's Lymphoma

SAF312A

Phase 2

Postoperative Pain

Dabrafenib

Phase 2

Cancer

Secukinmab

Phase 2

Rheumatoid Arthritis

KAF156

Phase 2

Malaria

indacaterol maleate / mometasone furoate

Phase 2

Asthma

QAV680 + Cetirizine

Phase 2

Allergic Rhinitis

Serelaxin

Phase 2

Coronary Artery Disease

Canakinumab (investigational)

Phase 2

Rheumatoid Arthritis

rMenB

Phase 2

Meningococcal Disease

TCH346

Phase 2

Amyotrophic Lateral Sclerosis

BYM338

Phase 2

Sporadic Inclusion Body Myositis

TKI258

Phase 2

Relapsed or Refractory Multiple Myeloma

LDE225

Phase 2

Medulloblastoma

Influenza vaccine surface antigen adjuvanted with MF59

Phase 2

Pandemic Influenza Disease

Trivalent influenza virus vaccine (TIV)

Phase 2

Human Influenza

AQW051

Phase 2

Schizophrenia

Eltrombopag

Phase 2

Myelodysplastic Syndromes

mometasone furoate

Phase 2

Asthma

LFG316

Phase 2

Non-infectious Intermediate Uveitis

QGE031

Phase 2

Asthma

INC424

Phase 2

Primary Myelofibrosis

RLX030 (serelaxin)

Phase 2

Chronic Heart Failure

TIV

Phase 2

Human Influenza

Influenza Trivalent Inactivated vaccines Novartis

Phase 2

Influenza

LDK378

Phase 2

Non-Small-Cell Lung Cancer

Adjuvanted influenza vaccine

Phase 2

Influenza Disease

MCS110

Phase 2

Advanced Triple Negative Breast Cancer (TNBC) With High TAMs

BGG492

Phase 2

Partial Onset Seizures

formoterol

Phase 2

Asthma

influenza vaccine

Phase 2

Influenza

QAX576

Phase 2

Asthma

Alum

Phase 2

Alzheimer's Disease

Iptacopan (LNP023)

Phase 2

Age-Related Macular Degeneration

Naproxen

Phase 2

Osteoarthritis

HSC835

Phase 2

Single Umbilical Cord Blood Transplantation

Patupilone

Phase 2

Carcinoma, Non-Small-Cell Lung

DFV890

Phase 2

Coronary Heart Disease

[177Lu]Lu-DOTA-TATE

Phase 2

Extensive Stage Small Cell Lung Cancer

Indacaterol acetate

Phase 2

Asthma

DNK333

Phase 2

Irritable Bowel Syndrome

LJN452

Phase 2

Primary Bile Acid Diarrhea

Tropifexor (LJN452)

Phase 2

Non-alcoholic Steatohepatitis (NASH)

VHB937

Phase 2

Amyotrophic Lateral Sclerosis (ALS)

LLG783

Phase 2

Peripheral Artery Disease (PAD); Intermittent Claudication

Iscalimab

Phase 2

Sjogren's Syndrome

Salmeterol

Phase 2

COPD

LXE408

Phase 2

Chagas Disease

KRP203 - 1.2mg

Phase 2

Subacute Cutaneous Lupus Erythematosus

Regulatory & News

Approvals, filings, and latest developments

Regulatory Approvals
NOVN.SW News